Velcade 1mg Injection: Effective Treatment for Cancer

Description:

• Velcade 1mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors.
• The active ingredient is Bortezomib.

Uses:

• Treatment of multiple myeloma (cancerous progression of plasma cells in the bone marrow).
• Treatment of mantle cell lymphoma (less common cancer affecting the lymph nodes).

Administration:

• Administered intravenously in your vein or subcutaneously under the skin.
• Should be given by a qualified healthcare professional experienced in the use of cytotoxic medications.
• Do not self-administer.

Side Effects:

• Serious: muscle cramps, confusion, visual disturbances, seizures, headache, breathlessness, swelling of feet, changes in heartbeat, high blood pressure, fainting and tiredness, cough and chest tightness.
• Common: pneumonia, loss of appetite, sensitivity, tingling and burning sensation of the skin, nausea, vomiting, diarrhea, mouth ulcers, constipation, muscle and bone pain, hair loss, fever, reduction in blood cell count, reduced kidney function, shivering, infections, itching and redness, dehydration, stomach problems, difficulty sleeping, anxiety, mood swings, depressed mood.

Precautions:

• Inform your doctor if you are allergic to Velcade 1mg Injection and its ingredients.
• Do not use this medication if you have severe lung or heart problems.
• Before starting treatment, let your physician know if you are suffering from neuropathy, cardiac disorders, severe lung problems, pulmonary disorders, posterior reversible encephalopathy syndrome disorders, gastrointestinal disorders, thrombocytopenia, neutropenia, tumor lysis syndrome, hepatic disorders.
• Inform your doctor of diabetes.
• Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.
• Keep this medicine out of sight and reach of children.

Safety Advices:

• Pregnancy: unsafe to use during pregnancy unless clearly necessary. Both women of childbearing potential and men must use an effective contraception method during and three months after treatment.
• Breast Feeding: unsafe to use during breastfeeding.
• Lungs: it is unknown whether Velcade 1mg Injection can be given to lung failure patients.
• Liver: inform your physician before starting this treatment if you have Hepatitis infection or liver disease.
• Alcohol: it is unsafe to consume alcohol with this medication.
• Driving: avoid driving or using machinery if you experience side effects like fainting, dizziness, tiredness, or blurred vision.

FAQs:

• Q 1. What is Velcade 1mg Injection used for?
  • Velcade 1mg Injection is mainly indicated to treat mantle cell lymphoma and multiple myeloma.
• Q 2. Can I drive while taking Velcade 1mg Injection?
  • Velcade 1mg Injection may cause dizziness, tiredness, fainting, or blurred vision. Hence, avoid driving and operating heavy machines while this Injection.
• Q 3. How is Velcade 1mg Injection given?
  • Velcade 1mg Injection is administered intravenously in your vein or subcutaneously under the skin by a doctor in a medical facility.
• Q 4. Is it safe to handle Velcade 1mg Injection while pregnant?
  • No, Pregnant women should not handle Velcade 1mg Injection as it contains cytotoxic agents. Using gloves and protective clothing is recommended to prevent skin contact.
• Q 5. What class of chemo is Velcade 1mg Injection?
  • Velcade 1mg Injection is a targeted therapy that belongs to the class of medicines called proteasome inhibitors.
• Q 6. Can I take Velcade 1mg Injection when I am pregnant?
  • Avoid taking Velcade 1mg Injection if you are pregnant, as it can cause harmful effects on the unborn baby. Females should use effective birth control methods during treatment and at least three months after treatment.
• Q 7. I am suffering from a Hepatitis infection. Can I take Velcade 1mg Injection?
  • Velcade 1mg Injection should not be used in patients with hepatitis infection because they might have a repeated attack of hepatitis, which can be fatal. If you have a history of hepatitis B infection, your doctor will carefully check you for signs of active hepatitis B.

Fact Box:

• Molecule name: Bortezomib.
• Therapeutic class: Antineoplastics agents.
• Pharmacological class: Proteasome inhibitor.
• Indications:
  • Multiple myeloma.
  • Mantle cell lymphoma.

Tags: cancer_treatment, velcade_injection, oncology_drug, injection_medicine, anti_cancer_drug